Influenza vaccine uptake ‘suboptimal’ in adults with early rheumatoid arthritis

Influenza vaccination coverage in adults with early rheumatoid arthritis in Canada remains “suboptimal,” according to data published in ACR Open Rheumatology.
“Despite the accessibility and affordability of effective vaccines, influenza significantly contributes to the mortality rate and health care burden in Canada, with yearly estimates of 12,000 hospitalizations and 3,500 deaths,” Viviane Ta, MSc, of McGill University, in Montreal, and colleagues wrote. “The incidence of influenza is higher in adults with rheumatoid arthritis (RA) than in the general population.”

Influenza vaccination coverage in adults with early rheumatoid arthritis in Canada remains “suboptimal,” according to data published in ACR Open Rheumatology.
“Despite the accessibility and affordability of effective vaccines, influenza significantly contributes to the mortality rate and health care burden in Canada, with yearly estimates of 12,000 hospitalizations and 3,500 deaths,” Viviane Ta, MSc, of McGill University, in Montreal, and colleagues wrote. “The incidence of influenza is higher in adults with rheumatoid arthritis (RA) than in the general population.”